Patents by Inventor Jacob E. Pananen

Jacob E. Pananen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160015888
    Abstract: A method and apparatus for a connection interface between a reservoir or syringe, infusion set tubing, and an infusion pump is provided. The reservoir, a base and a cap are connected to form an integrated unit that is capable of being inserted and secured in an infusion pump housing. The cap and the infusion pump are each provided with at least one sensor or at least one detectable feature, arranged to interact with at least one corresponding detectable feature or sensor on the other of the cap and infusion pump device, to detect one or more of the presence, position or other characteristic of the cap when the cap is aligned or coupled with the infusion pump housing. The detectable feature and sensor may be magnetic, RF, mechanical, optical or any combination.
    Type: Application
    Filed: July 20, 2015
    Publication date: January 21, 2016
    Inventors: R. Marie Tieck, Jacob E. Pananen, Afshin Bazargan, Juan M. Alderete, JR.
  • Publication number: 20160015956
    Abstract: A method and apparatus for a connection interface between a reservoir or syringe, infusion set tubing, and an infusion pump is provided. The reservoir, a base and a cap are connected to form an integrated unit that is capable of being inserted and secured in an infusion pump housing. The cap and the infusion pump are each provided with at least one sensor or at least one detectable feature, arranged to interact with at least one corresponding detectable feature or sensor on the other of the cap and infusion pump device, to detect one or more of the presence, position or other characteristic of the cap when the cap is aligned or coupled with the infusion pump housing. The detectable feature and sensor may be magnetic, RF, mechanical, optical or any combination.
    Type: Application
    Filed: July 16, 2015
    Publication date: January 21, 2016
    Inventors: R. Marie Tieck, Jacob E. Pananen, Afshin Bazargan, Juan M. Alderete, JR.
  • Patent number: 8298176
    Abstract: Drug solutions (or other combinations of vehicle with entrained drug) are prepared by removing drug from one or more masses of a solid form of the drug. The solid form of the drug may be sparingly soluble or insoluble in water. Examples of devices for holding solid drug and facilitating delivery of such drug to targeted regions are also described.
    Type: Grant
    Filed: July 19, 2010
    Date of Patent: October 30, 2012
    Assignee: NeuroSystec Corporation
    Inventors: Thomas J. Lobl, Anna Imola Nagy, Jacob E. Pananen, John V. Schloss
  • Patent number: 8267905
    Abstract: Implantable drug delivery systems target delivery of small volumes of drugs to specific tissues. In some cases, a drug delivery system includes an implantable osmotic pump connected to a drug-containing housing, with that housing connected to a needle, cochlear implant or other type of component for ultimate delivery to the target tissue. In some implementations, a subcutaneous port receives a fluid from an external pump. The port is connected to a needle or other component for delivery of one or more drugs to the target tissue. Both solid and liquid drug formulations can be used. In embodiments using solid drugs, a separate drug vehicle (such as saline) can be used to dissolve a portion of the solid drug, with the drug-loaded vehicle then delivered to the target tissue.
    Type: Grant
    Filed: May 1, 2006
    Date of Patent: September 18, 2012
    Assignee: NeuroSystec Corporation
    Inventors: Thomas J. Lobl, Stephen J. McCormack, Anna Imola Nagy, Jacob E. Pananen, John V. Schloss
  • Publication number: 20120208848
    Abstract: Improved formulations of gacyclidine for direct administration to the inner or middle ear.
    Type: Application
    Filed: April 25, 2012
    Publication date: August 16, 2012
    Applicant: NEUROSYSTEC CORPORATION
    Inventors: Thomas Jay Lobl, John Vinton Schloss, Jacob E. Pananen
  • Publication number: 20110136870
    Abstract: Improved formulations of gacyclidine for direct administration to the inner or middle ear.
    Type: Application
    Filed: February 4, 2011
    Publication date: June 9, 2011
    Applicant: NEUROSYSTEC CORPORATION
    Inventors: Thomas Jay Lobl, John Vinton Schloss, Stephen Joseph McCormack, Anna Imola Nagy, Jacob E. Pananen
  • Publication number: 20110071493
    Abstract: Drug solutions (or other combinations of vehicle with entrained drug) are prepared by removing drug from one or more masses of a solid form of the drug. The solid form of the drug may be sparingly soluble or insoluble in water. Examples of devices for holding solid drug and facilitating delivery of such drug to targeted regions are also described.
    Type: Application
    Filed: July 19, 2010
    Publication date: March 24, 2011
    Applicant: NEUROSYSTEC CORPORATION
    Inventors: Thomas J. Lobl, Anna Imola Nagy, Jacob E. Pananen, John V. Schloss
  • Publication number: 20100305551
    Abstract: A drug-delivery unit suitable for implantation into a patient body may include a valveless impedance pump. In some implementations the unit may include an actuator, control electronics and a battery, and may communicate with an external patient interface unit. The patient interface unit can be used to control operation of the implant and to download data from the implant. The patient interface unit can also be used to charge the implant and/or a separate charger can be used. In other implementations, a drug-delivery implant unit may lack internal electronics and instead rely on an externally-supplied magnetic field to actuate the pump.
    Type: Application
    Filed: June 4, 2010
    Publication date: December 2, 2010
    Applicant: NEUROSYSTEC CORP.
    Inventors: Thomas J. Lobl, Jacob E. Pananen, David L. Canfield, Anna I. Nagy, Adrian L. Krag
  • Patent number: 7803148
    Abstract: Drug solutions (or other combinations of vehicle with entrained drug) are prepared by removing drug from one or more masses of a solid form of the drug. The solid form of the drug may be sparingly soluble or insoluble in water. Examples of devices for holding solid drug and facilitating delivery of such drug to targeted regions are also described.
    Type: Grant
    Filed: June 7, 2007
    Date of Patent: September 28, 2010
    Assignee: NeuroSystec Corporation
    Inventors: Thomas J. Lobl, Anna Imola Nagy, Jacob E. Pananen, John V. Schloss
  • Publication number: 20090209945
    Abstract: A drug-delivery unit suitable for implantation into a patient body may include a valveless impedance pump. In some implementations the unit may include an actuator, control electronics and a battery, and may communicate with an external patient interface unit. The patient interface unit can be used to control operation of the implant and to download data from the implant. The patient interface unit can also be used to charge the implant and/or a separate charger can be used. In other implementations, a drug-delivery implant unit may lack internal electronics and instead rely on an externally-supplied magnetic field to actuate the pump.
    Type: Application
    Filed: January 19, 2009
    Publication date: August 20, 2009
    Applicant: NEUROSYSTEC CORPORATION
    Inventors: Thomas J. Lobl, Jacob E. Pananen, David L. Canfield, Anna I. Nagy, Adrian L. Krag
  • Publication number: 20080152694
    Abstract: Devices, systems and techniques for delivering drugs to an ocular tissue are described. In at least some embodiments, a terminal component (e.g., a needle or open end of a catheter) is implanted in an ocular tissue and used to deliver one or more drugs. The delivered drugs may come from a source which is also implanted, or may be introduced from an external source (e.g., via a port). Both solid and liquid drug formulations can be used. Ocular implants can alternatively include a thin film coating that releases a drug into an ocular tissue.
    Type: Application
    Filed: July 20, 2007
    Publication date: June 26, 2008
    Applicant: NEUROSYSTEC CORPORATION
    Inventors: Thomas J. Lobl, Anna Imola Nagy, Jacob E. Pananen, John V. Schloss
  • Publication number: 20080145439
    Abstract: A suspension of nanoparticles in a liquid medium provides a mechanism for delivery of gacyclidine base or other drug that is substantially insoluble in the liquid medium.
    Type: Application
    Filed: July 31, 2007
    Publication date: June 19, 2008
    Applicant: NEUROSYSTEC CORPORATION
    Inventors: Thomas J. Lobl, John V. Schloss, Anna Imola Nagy, Jacob E. Pananen
  • Publication number: 20080065002
    Abstract: A drug-compatible, biocompatible, drug-delivery catheter can include multi-lumen tubing attached to an end fitting, with the end fitting having an internal fluid chamber and a fluid exit region. The catheter can also include multi-lumen tubing having one or more needles attached at a distal end.
    Type: Application
    Filed: September 5, 2007
    Publication date: March 13, 2008
    Applicant: NEUROSYSTEC CORPORATION
    Inventors: Thomas J. Lobl, John V. Schloss, Anna Imola Nagy, Jacob E. Pananen
  • Publication number: 20070287984
    Abstract: Drug solutions (or other combinations of vehicle with entrained drug) are prepared by removing drug from one or more masses of a solid form of the drug. The solid form of the drug may be sparingly soluble or insoluble in water. Examples of devices for holding solid drug and facilitating delivery of such drug to targeted regions are also described.
    Type: Application
    Filed: June 7, 2007
    Publication date: December 13, 2007
    Applicant: NEUROSYSTEC CORPORATION
    Inventors: Thomas J. Lobl, Anna Imola Nagy, Jacob E. Pananen, John V. Schloss